PubRank

E Holler

Author PubWeight™ 142.66‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995 5.34
2 Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990 3.50
3 Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD. Bone Marrow Transplant 2011 1.85
4 Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells. Ann Neurol 1995 1.50
5 Catabolism of diadenosine 5',5"'-P1,P4-tetraphosphate in procaryotes. Purification and properties of diadenosine 5',5"'-P1,P4-tetraphosphate (symmetrical) pyrophosphohydrolase from Escherichia coli K12. J Biol Chem 1983 1.49
6 Mechanism of synthesis of adenosine(5')tetraphospho(5')adenosine (AppppA) by aminoacyl-tRNA synthetases. Eur J Biochem 1982 1.42
7 Critical involvement of transmembrane tumor necrosis factor-alpha in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin. Blood 1995 1.28
8 L-phenylalanyl-tRNA synthetase of Escherichia coli K-10. A reinvestigation of molecular weight and subunit structure. Eur J Biochem 1974 1.22
9 Reverse signaling through transmembrane TNF confers resistance to lipopolysaccharide in human monocytes and macrophages. J Immunol 2000 1.21
10 Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study. Bone Marrow Transplant 2001 1.20
11 Reaction of N-acetylglucosamine oligosaccharides with lysozyme. Temperature, pH, and solvent deuterium isotope effects; equilbrium, steady state, and pre-steady state measurements*. J Biol Chem 1975 1.20
12 Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 2004 1.17
13 Synthesis of diadenosine 5',5'''-P1,P4-tetraphosphate (AppppA) from adenosine 5'-phosphosulfate and adenosine 5'-triphosphate catalyzed by yeast AppppA phosphorylase. Biochemistry 1988 1.14
14 Productive and unproductive lysozyme-chitosaccharide complexes. Equilibrium measurements. Biochemistry 1975 1.13
15 On the active site topography of isoleucyl transfer ribonucleic acid synthetase of Escherichia coli B. Biochemistry 1973 1.13
16 Successful treatment of a refractory skin ulcer in chronic cutaneous GvHD after allogeneic HSCT with split-thickness skin allografting from the stem cell donor. Bone Marrow Transplant 2012 1.11
17 Kinetics of lysozyme-substrate interactions. Biochem Biophys Res Commun 1969 1.11
18 Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor. J Viral Hepat 2007 1.10
19 Acute pneumatosis cystoides intestinalis following allogeneic transplantation -- the surgeon's dilemma. Bone Marrow Transplant 2002 1.09
20 Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation. Blood 1997 1.07
21 Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease. Blood 1992 1.04
22 Polymorphisms of cytokine and innate immunity genes and GVHD. Best Pract Res Clin Haematol 2008 1.01
23 Assessing the potential role of photopheresis in hematopoietic stem cell transplant. Bone Marrow Transplant 2006 0.96
24 Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept. Bone Marrow Transplant 2005 0.96
25 Isoleucyl transfer ribonucleic acid synthetase of Escherichia coli B. A rapid kinetic investigation of the L-isoleucine-activating reaction. Biochemistry 1972 0.96
26 Structure-function analysis of mononucleotides and short oligonucleotides in the priming of enzymatic DNA synthesis. Biochemistry 1990 0.95
27 Circular dichroism and ordered structure of bisnucleoside oligophosphates and their Zn2+ and Mg2+ complexes. Biochemistry 1983 0.94
28 Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria. Biol Blood Marrow Transplant 2003 0.94
29 Clinical experience with posaconazole prophylaxis--a retrospective analysis in a haematological unit. Mycoses 2011 0.93
30 An unusual polyanion from Physarum polycephalum that inhibits homologous DNA polymerase alpha in vitro. Biochemistry 1989 0.93
31 Late pulmonary impairment following allogeneic bone marrow transplantation. Eur J Med Res 1996 0.93
32 Adoptive immunotherapy with donor lymphocyte transfusions. Curr Opin Oncol 1997 0.93
33 Chemokine and chemokine receptor expression analysis in target organs of acute graft-versus-host disease. Genes Immun 2009 0.93
34 2-p-Toluidinylnaphthalene-6-sulfonate, a fluorescent reporter group for L-isoleucyl-tRNA synthetase. Biochem Biophys Res Commun 1971 0.93
35 Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications. Bone Marrow Transplant 2005 0.92
36 Adoptive immunotherapy in canine chimeras. Transplantation 1997 0.92
37 Specificity and direction of depolymerization of beta-poly(L-malate) catalysed by polymalatase from Physarum polycephalum--fluorescence labeling at the carboxy-terminus of beta-poly(L-malate). Eur J Biochem 1997 0.92
38 Angiitis of the central nervous system after allogeneic bone marrow transplantation? Stroke 1999 0.92
39 Endothelial apoptosis is induced by serum of patients after cardiopulmonary bypass. Eur J Cardiothorac Surg 2000 0.91
40 Cerebral involvement in graft-versus-host disease after murine bone marrow transplantation. Neurology 2001 0.91
41 Differentiation of human tumour-associated dendritic cells into endothelial-like cells: an alternative pathway of tumour angiogenesis. Scand J Immunol 2007 0.91
42 The reaction of platinum(II) complexes with DNA. Kinetics of intrastrand crosslink formation in vitro. Nucleic Acids Res 1991 0.91
43 Kinetic investigation of the DNA platination reaction: evidence for a transient adduct between deoxyribonucleic acid and cis-platinum(II). Biochemistry 1987 0.90
44 Interferon (IFN)-gamma is a main mediator of keratinocyte (HaCaT) apoptosis and contributes to autocrine IFN-gamma and tumour necrosis factor-alpha production. Br J Dermatol 2005 0.90
45 Cellular distribution and cellular reactivity of platinum (II) complexes. Biochem Pharmacol 1996 0.89
46 Synthetic substrates and inhibitors of beta-poly(L-malate)-hydrolase (polymalatase). Eur J Biochem 2000 0.88
47 No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients. Ann Oncol 2011 0.88
48 Variations in 1 alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 serum levels during allogeneic bone marrow transplantation. Bone Marrow Transplant 2004 0.88
49 Interleukin-10 promotes NK cell killing of autologous macrophages by stimulating expression of NKG2D ligands. Scand J Immunol 2010 0.87
50 Multiple sclerosis: prospective analysis of TNF-alpha and 55 kDa TNF receptor in CSF and serum in correlation with clinical and MRI activity. J Neuroimmunol 1996 0.87
51 Modification of L-isoleucyl-tRNA synthetase with L-isoleucyl-bromomethyl ketone. The effect of the catalytic steps. Eur J Biochem 1977 0.87
52 Ionizing radiation induces human intercellular adhesion molecule-1 in vitro. J Invest Dermatol 1994 0.87
53 Catalytic mechanism of phenylalanyl-tRNA synthetase of Escherichia coli K10. Conformational change and tRNAPhe phenylalanylation are concerted. Biochemistry 1982 0.87
54 Extracorporeal photopheresis in 62 patients with acute and chronic GVHD: results of treatment with the COBE Spectra System. Bone Marrow Transplant 2012 0.86
55 Peripheral blood mononuclear cells induce programmed cell death in human endothelial cells and may prevent repair: role of cytokines. Blood 1997 0.86
56 NKG2D-dependent effector function of bronchial epithelium-activated alloreactive T-cells. Eur Respir J 2008 0.86
57 Beta-poly(L-malate) production by non-growing microplasmodia of Physarum polycephalum. Effects of metabolic intermediates and inhibitors. FEMS Microbiol Lett 2000 0.85
58 Escherichia coli DNA polymerase I: inherent exonuclease activities differentiate between monofunctional and bifunctional adducts of DNA and cis- or trans-diamminedichloroplatinum(II). An exonuclease investigation of the kinetics of the adduct formation. Eur J Biochem 1990 0.85
59 Expression of heme oxygenase-1 protects endothelial cells from irradiation-induced apoptosis. Endothelium 2005 0.84
60 Phenylalanyl-tRNA synthetase induced conformational change of Escherichia coli tRNA phe. Biochemistry 1979 0.84
61 The catalytic mechanism of amino acid:tRNA ligases. Synergism and formation of the ternary enzyme-amino acid-ATP complex. Biochemistry 1975 0.84
62 Early allo-SCT for AML with a complex aberrant karyotype--results from a prospective pilot study. Bone Marrow Transplant 2011 0.83
63 Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease. Bone Marrow Transplant 2006 0.83
64 Pharmaceutical and cellular strategies in prophylaxis and treatment of graft-versus-host disease. Curr Pharm Des 2009 0.83
65 L-phenylalanine:tRNA ligase of Escherichia coli K10. A rapid kinetic investigation of the catalytic reaction. Biochemistry 1975 0.83
66 Low-dose ARAC, donor cells, and GM-CSF for treatment of recurrent acute myeloid leukemia after allogeneic stem cell transplantation. Leukemia 2004 0.83
67 Outcome of hemato-oncologic patients with and without stem cell transplantation in a medical ICU. Eur J Med Res 2007 0.83
68 Acute deterioration of Charcot-Marie-Tooth disease IA (CMT IA) following 2 mg of vincristine chemotherapy. Ann Oncol 2000 0.83
69 Phenylalanyl-tRNA synthetase from Escherichia coli K10. Synergistic coupling between the sites for binding of L-phenylalanine and ATP. Eur J Biochem 1973 0.83
70 Histological correlation between different centers using the skin explant model to predict graft-versus-host disease following bone marrow transplantation. Hum Immunol 2001 0.82
71 Neurological and neuroradiological findings in long-term survivors of allogeneic bone marrow transplantation. Ann Neurol 1998 0.82
72 Different types of human leukemias express the message for TNF-alpha and interleukin-10. Eur J Med Res 2001 0.82
73 Effects of coordination of diammineplatinum(II) with DNA on the activities of Escherichia coli DNA polymerase I. Biochemistry 1988 0.82
74 A rare case of acute myeloid leukemia with a CHIC2-ETV6 fusiongen and multiple other molecular aberrations. Leukemia 2005 0.82
75 Active site stoichiometry of L-phenylalanine: tRNA ligase from Escherichia coli K(-10). J Biol Chem 1975 0.82
76 Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease. Bone Marrow Transplant 1997 0.81
77 Equilibrium analysis of L-Phe-tRNA Phe complexes with L-phenylalanyl transfer ribonucleic acid synthetase of Escherichia coli K 10. Biochemistry 1974 0.81
78 Recipient NOD2/CARD15 status affects cellular infiltrates in human intestinal graft-versus-host disease. Clin Exp Immunol 2009 0.81
79 Platinum compounds with estrogen receptor affinity. Cancer Treat Rev 1990 0.81
80 Transmural penetration of intravenously applied microbubbles during contrast-enhanced ultrasound as a new diagnostic feature in patients with GVHD of the bowel. Bone Marrow Transplant 2010 0.81
81 Isolated cerebral manifestation of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation: a case of clinical and diagnostic challenges. Transpl Infect Dis 2011 0.81
82 Mode of inhibition of the DNA polymerase of Methanococcus vannielii by aphidicolin. Eur J Biochem 1987 0.81
83 Use of intrathecal prophylaxis in allogeneic haematopoietic stem cell transplantation for malignant blood diseases: a survey of the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 2005 0.81
84 Nuclear accumulation and homeostasis of the unusual polymer beta-poly (L-malate) in plasmodia of Physarum polycephalum. Eur J Cell Biol 1996 0.80
85 Labelling of the catalytic site of lysozyme. Biochem Biophys Res Commun 1969 0.80
86 Purification and characterization of DNA polymerase alpha from plasmodia of Physarum polycephalum. Eur J Biochem 1988 0.80
87 Personality influences quality-of-life assessments in adult patients after allogeneic hematopoietic SCT: results from a joint evaluation of the prospective German Multicenter Validation Trial and the Fred Hutchinson Cancer Research Center. Bone Marrow Transplant 2012 0.79
88 Protein biosynthesis: the codon-specific activation of amino acids. Angew Chem Int Ed Engl 1978 0.79
89 Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure. Blood 1999 0.79
90 Effect of growth factors on estrogen receptor mediated gene expression. J Steroid Biochem Mol Biol 1996 0.79
91 Labelling of L-isoleucine tRNA ligase from Escherichia coli with L-isoleucyl-bromomethyl ketone. Eur J Biochem 1976 0.79
92 Parameters of the fibrinolytic system in patients undergoing BMT: elevation of PAI-1 in veno-occlusive disease. Bone Marrow Transplant 1994 0.79
93 Ring-substituted diaqua(1,2-diphenylethylenediamine)platinum(II) sulfate reacts with DNA through a dissociable complex. Eur J Biochem 1992 0.79
94 Increased DNA-binding activity of cis-1,1-cyclobutanedicarboxylatodiammineplatinum(II) (carboplatin) in the presence of nucleophiles and human breast cancer MCF-7 cell cytoplasmic extracts: activation theory revisited. Biochem Pharmacol 1999 0.79
95 Noncovalent complexes of diadenosine 5',5"'-P1,P4-tetraphosphate with divalent metal ions, biogenic amines, proteins and poly(dT). Biochem Biophys Res Commun 1984 0.79
96 Laboratory markers of veno-occlusive disease in the course of bone marrow and subsequent liver transplantation. Bone Marrow Transplant 1997 0.79
97 Investigations on the antiproliferative effects of amino acid antagonists targeting for aminoacyl-tRNA synthetases. Part II--The antileukemic effect. Arch Pharm (Weinheim) 1989 0.79
98 Successful treatment of Scedosporium apiospermum soft tissue abscess with caspofungin and voriconazole in a severely immunocompromised patient with acute myeloid leukemia. Transpl Infect Dis 2010 0.79
99 Kinetics of acyl transfer ribonucleic acid complexes of Escherichia coli phenylalanyl-tRNA synthetase. A conformational change is rate limiting in catalysis. Biochemistry 1982 0.79
100 Protein kinase C activation is involved in ultraviolet B irradiation-induced endothelial cell ICAM-1 up-regulation and lymphocyte-endothelium interaction in vitro. Scand J Immunol 1996 0.78
101 Human parvovirus B19-associated disease in bone marrow transplantation. Infection 1999 0.78
102 Phenylalanyl-tRNA synthetase of Escherichia coli K10. Effects of zinc(II) on partial reactions of diadenosine 5',5"'-P1,P4-tetraphosphate synthesis, conformation, and protein aggregation. Biochemistry 1984 0.78
103 Levels of the terminal complement complex, C3a-desArg and C1-inhibitor in adult patients with capillary leak syndrome following bone marrow transplantation. Ann Hematol 1995 0.78
104 1-Carbamoylalkyl-2-phenylindoles: relationship between side chain structure and estrogen antagonism. J Steroid Biochem Mol Biol 1994 0.78
105 [Graft-versus-Host Disease (GvHD) - an update : Part 1: Pathophysiology, clinical features and classification of GvHD]. Hautarzt 2011 0.78
106 Molecular constituents of the replication apparatus in the plasmodium of Physarum polycephalum: identification by photoaffinity labelling. Microbiology 1998 0.78
107 Naive monocytes can trigger transendothelial migration of peripheral blood cells through the induction of endothelial tumour necrosis factor-alpha. Scand J Immunol 2000 0.78
108 Increased levels of tissue plasminogen activator (t-PA) and tissue plasminogen activator inhibitor (PAI) correlate with tumor necrosis factor alpha (TNF alpha)-release in patients suffering from microangiopathy following allogeneic bone marrow transplantation (BMT). Thromb Res 1992 0.78
109 Multiple polypeptides immunologically related to beta-poly(L-malate) hydrolase (polymalatase) in the plasmodium of the slime mold Physarum polycephalum. Eur J Biochem 1998 0.78
110 DNA polymerase delta of Physarum polycephalum. Curr Genet 1995 0.78
111 Myeloablative conditioning for marrow transplantation in myelodysplastic syndromes and paroxysmal nocturnal haemoglobinuria. Bone Marrow Transplant 1989 0.78
112 Influence of bacterial endotoxin on radiation-induced activation of human endothelial cells in vitro and in vivo: protective role of IL-10. Transplantation 1996 0.78
113 A rapid luciferase transfection assay for transcription activation effects and stability control of estrogenic drugs in cell cultures. J Cancer Res Clin Oncol 1994 0.78
114 Validation of an automated enzyme immunoassay for Interleukin-6 for routine clinical use. Clin Chem Lab Med 1998 0.78
115 Catalytic mechanism of phenylalanyl-tRNA synthetase of Escherichia coli K10. Different properties of native and photochemically cross-linked tRNAPhe can be explained in the light of tRNA conformer equilibria. Biochemistry 1981 0.78
116 Kinetics of lysozyme-substrate interactions. Biochem Biophys Res Commun 1970 0.78
117 Influence of bacterial endotoxin on radiation-induced activation of human endothelial cells in vitro and in vivo: interleukin-10 protects against transendothelial migration. Transplantation 1997 0.78
118 Influence of bacterial endotoxin on the allogenicity of human endothelial cells. Bone Marrow Transplant 1998 0.78
119 L-Phenylalanine: tRNA ligase of Escherichia coli K10. The effect of O replaced by S substitution on substrate and ligand binding properties of ATP. Eur J Biochem 1976 0.77
120 Treatment of steroid-resistant acute GVHD with OKT3 and high-dose steroids results in better disease control and lower incidence of infectious complications when compared to high-dose steroids alone: a randomized multicenter trial by the EBMT Chronic Leukemia Working Party. Leukemia 2007 0.77
121 Investigations on the antiproliferative effects of amino acid antagonists targeting for aminoacyl-tRNA synthetases. Part I--The antibacterial effect. Arch Pharm (Weinheim) 1989 0.77
122 Treatment of aGVHD with OKT3: clinical outcome and side-effects associated with release of TNF alpha. Bone Marrow Transplant 1991 0.77
123 The impact of antithymocyte globulin on short-term toxicity after allogeneic stem cell transplantation. Bone Marrow Transplant 2002 0.77
124 Immunological characterization of canine hematopoietic progenitor cells. Ann Hematol 1991 0.77
125 Rearrangement of an abortive aminoacyl-tRNA synthetase complex with aminoacyl-tRNA could be rate-determining for catalytic charging. J Biol Chem 1976 0.77
126 Graft-versus-host reaction spares normal stem cells in chronic myelogenous leukemia. Bone Marrow Transplant 1996 0.77
127 Studies on the mechanism of tolerance or graft-versus-host disease in allogeneic bone marrow recipients at the level of cytotoxic T-cell precursor frequencies. Blood 1992 0.77
128 OKT3 muromonab as second-line and subsequent treatment in recipients of stem cell allografts with steroid-resistant acute graft-versus-host disease. Bone Marrow Transplant 2005 0.77
129 Phenylalanyl-tRNA synthetase of Escherichia coli K 10. Multiple enzyme-aminoacyl-tRNA complexes as a consequence of substrate specificity. Biochemistry 1979 0.77
130 Large complexes of beta-poly(L-malate) with DNA polymerase alpha, histones, and other proteins in nuclei of growing plasmodia of Physarum polycephalum. Biochemistry 1995 0.77
131 The determination of the dissociation constants of productive and unproductive lysozyme substrate complexes. FEBS Lett 1974 0.77
132 Protein C and procollagen III peptide levels in patients with hepatic dysfunction after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2005 0.77
133 Thermal decomposition of fungal poly(beta,L-malic acid) and Poly(beta,L-malate)s. Biomacromolecules 2006 0.77
134 Rapid achievement of complete donor chimerism and low regimen-related toxicity after reduced conditioning with fludarabine, carmustine, melphalan and allogeneic transplantation. Bone Marrow Transplant 2000 0.77
135 Helix-coil transitions in DNA using a pH variation method: case of a melting paradox as a function of ionic strength. Anal Biochem 1996 0.77
136 Monoclonal antibody and receptor antagonist therapy for GVHD. Cancer Treat Res 1999 0.77
137 Monoclonal anti TNF alpha antibody in the treatment of acute GvHD refractory both to corticosteroids and anti IL-2 R antibody. Bone Marrow Transplant 1991 0.77
138 Interaction of DNA polymerase I of Escherichia coli with nucleotides. Antagonistic effects of single-stranded polynucleotide homopolymers. Biochemistry 1985 0.77
139 Functional characterization of canine lymphocyte subsets. Ann Hematol 1991 0.77
140 Is beta-poly(L-malate) synthesis catalysed by a combination of beta-L-malyl-AMP-ligase and beta-poly(L-malate) polymerase? Eur J Biochem 1999 0.77
141 Differential role of protein kinase C in cytokine induced lymphocyte-endothelium interaction in vitro. Scand J Immunol 1994 0.76
142 MIP-3α expression in macrophages is NOD dependent. Digestion 2012 0.76
143 Human leukocyte antigen distribution in German Caucasians with advanced Ewing's sarcoma. Klin Padiatr 2012 0.76
144 Changes in skeletal muscle pO2 after administration of anti-TNF alpha-antibody in patients with severe sepsis: comparison to interleukin-6 serum levels, APACHE II, and Elebute scores. Shock 1994 0.76
145 Mechanism of phenylalanyl-tRNA synthetase of Escherichia coli K. 10. Modulation of catalytic properties by magnesium. Biochemistry 1979 0.76
146 Preparative synthesis of beta-L-malyl-coenzyme A assisted by malyl-coenzyme A synthetase from Pseudomonas AM1. Anal Biochem 1995 0.76
147 Dose rate and fractionation of total body irradiation in dogs: short and long term effects. Radiother Oncol 1990 0.76
148 Flow cytometric findings in platelets of patients following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2002 0.76
149 Contrast-enhanced ultrasound for differential diagnosis of suspected GvHD in patients after allogeneic transplantation. Clin Hemorheol Microcirc 2011 0.76
150 Productive and unproductive lysozyme-chitosaccharide complexes. Kinetic investigations. Biochemistry 1975 0.76
151 Oligotide, a defibrotide derivative, protects human microvascular endothelial cells against fludarabine-induced activation, damage and allogenicity. Bone Marrow Transplant 2005 0.76
152 Selective labelling of the beta-subunit of L-phenylalanyl-tRNA synthetase from E. coli with N-bromoacetyl-L-phenylalanyl-tRNA Phe. Biochem Biophys Res Commun 1974 0.76
153 The binding of adenosine(5')tetraphospho(5')adenosine to calf thymus histones measured by non-equilibrium dialysis. Biochem J 1987 0.75
154 Monitoring of veno-occlusive disease after bone-marrow transplantation by serum aminopropeptide of type III procollagen. Lancet 1993 0.75
155 The detection of apoptosis in a human in vitro skin explant assay for graft versus host reactions. J Clin Pathol 2002 0.75
156 Identification and validation of biomarkers associated with acute and chronic graft versus host disease. Bone Marrow Transplant 2016 0.75
157 [Trust in medicine, especially in surgery]. Chirurg 1994 0.75
158 Granulocyte colony-stimulating factor inhibits the endogenous leukotriene production in tumour patients. Br J Haematol 1994 0.75
159 [A 56-year-old patient with bronchial asthma and massive psoas muscle hematoma]. Internist (Berl) 1986 0.75
160 [Abdominal pain attacks and hyponatremia]. Internist (Berl) 1987 0.75
161 Adoptive immunotherapy in human and canine chimeras. Bone Marrow Transplant 1993 0.75
162 Hemostatic parameters in sepsis patients treated with anti-TNF alpha-monoclonal antibodies. Shock 1996 0.75
163 Differential modulation of IL-1-induced endothelial adhesion molecules and transendothelial migration of granulocytes by G-CSF. Br J Haematol 1997 0.75
164 Successful treatment with high-dose intravenous immunoglobulin in a patient with spontaneous inhibitor to factor VIII. Blut 1986 0.75
165 Non-disruptive detection of DNA polymerases in nondenaturing polyacrylamide gels. Eur J Biochem 1985 0.75
166 [A female patient with cardiac insufficiency, hypertension, systolic heart and paraumbilical murmurs]. Internist (Berl) 1985 0.75
167 Catalytic mechanism of isoleucyl-tRNA synthetase of Escherichia coli K10. Effect of pH and chemical modification. Biochemistry 1980 0.75
168 Phenylalanyl-tRNA synthetase of baker's yeast. Modulation of adenosine triphosphate-pyrophosphate exchange by transfer ribonucleic acid. Biochemistry 1981 0.75
169 [Diagnosis and therapy of lung infiltrates in febrile neutropenic patients. Standard recommendations of the Work Group of Infections in Hematology and Oncology of the German Association of Hematology and Oncology]. Dtsch Med Wochenschr 1999 0.75
170 Vaccination against pandemic H1N1 (2009) in patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis. Infection 2011 0.75
171 DNA polymerase alpha--primase complex of Physarum polycephalum. Cell Biol Int Rep 1992 0.75
172 Platinum incorporation and differential effects of cis- and trans-diamminedichloroplatinum(II) on the growth of mouse leukemia P388/D1. Cancer Res 1989 0.75
173 Bone marrow transplantation for the treatment of leukaemia-results of the Munich Cooperative Group. Folia Haematol Int Mag Klin Morphol Blutforsch 1989 0.75
174 L-phenylalanyl-tRNA synthetase of E. coli. Active site specific binding of 2-p-toluidinylnaphthalene-6-sulfonate. Biochem Biophys Res Commun 1973 0.75
175 Cancer after bone marrow transplantation. IBMTR and EBMT/EULEP Study Group on Late Effects. Bone Marrow Transplant 1992 0.75
176 Repeated administration of a F(ab')2 fragment of an anti-tumor necrosis factor alpha monoclonal antibody in patients with severe sepsis: effects on the cardiovascular system and cytokine levels. Shock 1994 0.75
177 [Phenylalanyl-tRNA synthetase (PRS) from Escherichia coli: binding of substrates and effectors]. Hoppe Seylers Z Physiol Chem 1972 0.75
178 Enhancement of tryptic esterase activity. J Theor Biol 1971 0.75
179 [Graft versus host disease with fatal outcome after administration of filtered erythrocyte concentrates]. Beitr Infusionsther 1992 0.75
180 [Radiobiologic considerations about further development of whole-body irradiation with subsequent bone marrow transplantation applied during the treatment of acute leukemia (author's transl)]. Strahlentherapie 1981 0.75
181 A DNA polymerase with unusual properties from the slime mold Physarum polycephalum. Eur J Biochem 1987 0.75
182 [Hypercoagulability in patients with veno-occlusive disease after bone marrow transplantation]. Med Klin (Munich) 1994 0.75
183 Investigations on the antiproliferative effects of amino acid antagonists targeting for aminoacyl-tRNA synthetases. Part III--Combination experiments. Arch Pharm (Weinheim) 1991 0.75
184 Improved survival following HLA-incompatible bone marrow transplantation. Munich Cooperative Group of Bone Marrow Transplantation. Folia Haematol Int Mag Klin Morphol Blutforsch 1989 0.75
185 [The mode of action of antimycobacterial benzylamines]. Arch Pharm (Weinheim) 1989 0.75
186 [Epidemiology and interventional treatment strategies of infectious complications after allogenic stem-cell transplantation]. Dtsch Med Wochenschr 2001 0.75
187 Hepatic veno-occlusive disease following peripheral blood stem cell or bone marrow transplantation. Haematologica 1999 0.75
188 [Inhibition of trypsin catalysis by cationic carbonic acid esters and amides]. Eur J Biochem 1970 0.75
189 Bispecific antibody fragments with CD20 X CD28 specificity allow effective autologous and allogeneic T-cell activation against malignant cells in peripheral blood and bone marrow cultures from patients with B-cell lineage leukemia and lymphoma. Exp Hematol 1999 0.75
190 The relevance of plasminogen activator inhibitor 1 (PAI-1) as a marker for the diagnosis of hepatic veno-occlusive disease in patients after bone marrow transplantation. Leuk Lymphoma 1999 0.75
191 Fluorescence and stopped-flow studies on the N in equilibrium F transition of serumalbumin. Biophys Chem 1975 0.75
192 Protein C, protein S and antithrombin III levels in the course of bone marrow and subsequent liver transplantation due to veno-occlusive disease. Eur J Med Res 1996 0.75
193 Immunomodulation by IFN-γ in patients with resistant infections and accompanying bronchiolitis obliterans following allo-SCT. Bone Marrow Transplant 2010 0.75
194 Hyperfractionation of total-body irradiation and engraftment of marrow from DLA-haploidentical littermates. Transplant Proc 1987 0.75
195 Hematopoietic transplantation: state of the art. Stem Cells 1997 0.75
196 In vitro competition between adenosine(5')tetraphospho(5')adenosine and deoxyribonucleic acid in the reaction with diamminedichloroplatinum(II). Eur J Biochem 1986 0.75
197 [Adriamycin and autologous bone marrow transplantation. Preclinical studies in dogs (author's transl)]. Blut 1982 0.75
198 [Bone marrow transplantation--indications and results]. Fortschr Med 1988 0.75
199 [Local treatment of epistaxis due to thrombopenia]. Dtsch Med Wochenschr 1987 0.75
200 Isoleucyl transfer ribonucleic acid synthetase of Escherichia coli B. Effects of magnesium and spermine on the amino acid activation reaction. Biochemistry 1973 0.75
201 [Graft-versus-host disease (GvHD) - an update. Part 2: prognosis and therapy of GvHD]. Hautarzt 2011 0.75
202 Enhanced levels of cyclic AMP, adenosine(5')tetraphospho(5')adenosine and nucleoside 5'-triphosphates in mouse leukemia P388/D1 after treatment with cis-diamminedichloroplatinum(II). Biochem Pharmacol 1991 0.75
203 [Isoleucyl-tRNA-synthetase: inhibition of isoleucyladenylate synthesis due to spermine]. Hoppe Seylers Z Physiol Chem 1972 0.75
204 Rapid determination of an amino acid: tRNA ligase.aminoacyl adenylate complex on DEAE-cellulose filter disks. Anal Biochem 1976 0.75
205 Serological identification and separation of canine lymphocyte subpopulations. Exp Hematol 1984 0.75
206 [Therapy of a patient with graft versus host reaction following allogenic bone marrow transplantation with the monoclonal antibody OKT3 (Orthoclone OKT3)]. Internist (Berl) 1989 0.75
207 Helix-coil transitions in DNA by novel Pt(II) complexes: a pH melting study. J Biomol Struct Dyn 1998 0.75
208 Adoptive immunotherapy in human and canine chimeras--the role of interferon alfa. EBMT Chronic Leukemia Working Party. Semin Hematol 1993 0.75
209 In vitro monitoring of endothelial complications following hematopoietic allogeneic stem cell transplantation. Bone Marrow Transplant 2004 0.75
210 Phenylalanyl-tRNA synthetase from E. coli: synergistic coupling between the sites for binding of L-phenylalanine and ATP. Biochem Biophys Res Commun 1973 0.75
211 Detection of ligand-induced conformational changes in phenylalanyl-tRNA synthetase of Escherichia coli K10 by laser light scattering. Biochemistry 1981 0.75
212 Changes in platelet membrane glycoproteins before bone marrow transplantation and after engraftment--a pilot study. Eur J Med Res 1998 0.75
213 Kinetics of anticooperative binding of phenylalanyl-tRNAPhe and tRNAPhe to phenylalanyl-tRNA synthetase of Escherichia coli K10. Biochemistry 1980 0.75
214 [Cutaneous manifestations of graft-versus-host disease]. Med Klin (Munich) 2001 0.75